nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP3A4—type 2 diabetes mellitus	0.128	1	CbGaD
Ketamine—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0346	0.0561	CbGbCtD
Ketamine—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0346	0.0561	CbGbCtD
Ketamine—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.032	0.0518	CbGbCtD
Ketamine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0276	0.0448	CbGbCtD
Ketamine—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0262	0.0425	CbGbCtD
Ketamine—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0252	0.0408	CbGbCtD
Ketamine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0243	0.0393	CbGbCtD
Ketamine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0221	0.0358	CbGbCtD
Ketamine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.021	0.034	CbGbCtD
Ketamine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.02	0.0324	CbGbCtD
Ketamine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0193	0.0312	CbGbCtD
Ketamine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0187	0.0303	CbGbCtD
Ketamine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0184	0.0299	CbGbCtD
Ketamine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0178	0.0289	CbGbCtD
Ketamine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0176	0.0286	CbGbCtD
Ketamine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0164	0.0266	CbGbCtD
Ketamine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0145	0.0235	CbGbCtD
Ketamine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0139	0.0226	CbGbCtD
Ketamine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0139	0.0226	CbGbCtD
Ketamine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0135	0.0219	CbGbCtD
Ketamine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0129	0.0208	CbGbCtD
Ketamine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0126	0.0204	CbGbCtD
Ketamine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0124	0.0201	CbGbCtD
Ketamine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0114	0.0184	CbGbCtD
Ketamine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0112	0.0182	CbGbCtD
Ketamine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0106	0.0171	CbGbCtD
Ketamine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0103	0.0166	CbGbCtD
Ketamine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0101	0.0164	CbGbCtD
Ketamine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00936	0.0152	CbGbCtD
Ketamine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00929	0.0151	CbGbCtD
Ketamine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00896	0.0145	CbGbCtD
Ketamine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00811	0.0131	CbGbCtD
Ketamine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00714	0.0116	CbGbCtD
Ketamine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00693	0.0112	CbGbCtD
Ketamine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00653	0.0106	CbGbCtD
Ketamine—ABCB1—Losartan—type 2 diabetes mellitus	0.00633	0.0103	CbGbCtD
Ketamine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00614	0.00995	CbGbCtD
Ketamine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00589	0.00954	CbGbCtD
Ketamine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00589	0.00954	CbGbCtD
Ketamine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00557	0.00902	CbGbCtD
Ketamine—Airway obstruction NOS—Losartan—type 2 diabetes mellitus	0.00509	0.0541	CcSEcCtD
Ketamine—GRIN2C—nerve—type 2 diabetes mellitus	0.00428	0.114	CbGeAlD
Ketamine—TACR1—peripheral nervous system—type 2 diabetes mellitus	0.00417	0.111	CbGeAlD
Ketamine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00415	0.00672	CbGbCtD
Ketamine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00379	0.00615	CbGbCtD
Ketamine—Obstructive airways disorder—Losartan—type 2 diabetes mellitus	0.00368	0.0391	CcSEcCtD
Ketamine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00348	0.0927	CbGeAlD
Ketamine—GRIN2B—nerve—type 2 diabetes mellitus	0.00339	0.0901	CbGeAlD
Ketamine—TACR1—nerve—type 2 diabetes mellitus	0.00325	0.0864	CbGeAlD
Ketamine—GRIN2A—nerve—type 2 diabetes mellitus	0.00296	0.0788	CbGeAlD
Ketamine—Epilepsy—Orlistat—type 2 diabetes mellitus	0.00269	0.0285	CcSEcCtD
Ketamine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00234	0.0623	CbGeAlD
Ketamine—OPRM1—nerve—type 2 diabetes mellitus	0.0018	0.0479	CbGeAlD
Ketamine—SLC6A2—nerve—type 2 diabetes mellitus	0.00132	0.0351	CbGeAlD
Ketamine—DRD2—nerve—type 2 diabetes mellitus	0.0012	0.032	CbGeAlD
Ketamine—Diplopia—Glipizide—type 2 diabetes mellitus	0.00118	0.0125	CcSEcCtD
Ketamine—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00118	0.0125	CcSEcCtD
Ketamine—Cystitis noninfective—Gliclazide—type 2 diabetes mellitus	0.0011	0.0117	CcSEcCtD
Ketamine—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00109	0.0116	CcSEcCtD
Ketamine—Cystitis—Gliclazide—type 2 diabetes mellitus	0.00109	0.0115	CcSEcCtD
Ketamine—Erythema—Tolazamide—type 2 diabetes mellitus	0.00107	0.0114	CcSEcCtD
Ketamine—Erythema—Acarbose—type 2 diabetes mellitus	0.00103	0.0109	CcSEcCtD
Ketamine—Bladder pain—Gliclazide—type 2 diabetes mellitus	0.00102	0.0108	CcSEcCtD
Ketamine—TACR1—adipose tissue—type 2 diabetes mellitus	0.001	0.0267	CbGeAlD
Ketamine—Diplopia—Bromocriptine—type 2 diabetes mellitus	0.000995	0.0106	CcSEcCtD
Ketamine—Laryngospasm—Ramipril—type 2 diabetes mellitus	0.00096	0.0102	CcSEcCtD
Ketamine—Diplopia—Glyburide—type 2 diabetes mellitus	0.00091	0.00965	CcSEcCtD
Ketamine—OPRD1—kidney—type 2 diabetes mellitus	0.000904	0.0241	CbGeAlD
Ketamine—PTGS1—artery—type 2 diabetes mellitus	0.000885	0.0235	CbGeAlD
Ketamine—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.000883	0.00937	CcSEcCtD
Ketamine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000867	0.0092	CcSEcCtD
Ketamine—Erythema—Repaglinide—type 2 diabetes mellitus	0.00086	0.00913	CcSEcCtD
Ketamine—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.000835	0.00886	CcSEcCtD
Ketamine—Diplopia—Gliclazide—type 2 diabetes mellitus	0.000817	0.00867	CcSEcCtD
Ketamine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.000777	0.00824	CcSEcCtD
Ketamine—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.000761	0.00808	CcSEcCtD
Ketamine—PTGS1—endothelium—type 2 diabetes mellitus	0.000747	0.0199	CbGeAlD
Ketamine—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.000731	0.00775	CcSEcCtD
Ketamine—Erythema—Glipizide—type 2 diabetes mellitus	0.000712	0.00755	CcSEcCtD
Ketamine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000702	0.00745	CcSEcCtD
Ketamine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000701	0.00744	CcSEcCtD
Ketamine—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.000696	0.00739	CcSEcCtD
Ketamine—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.000682	0.00723	CcSEcCtD
Ketamine—Rash—Miglitol—type 2 diabetes mellitus	0.000675	0.00716	CcSEcCtD
Ketamine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000674	0.00716	CcSEcCtD
Ketamine—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000671	0.00712	CcSEcCtD
Ketamine—Erythema—Glimepiride—type 2 diabetes mellitus	0.000664	0.00705	CcSEcCtD
Ketamine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000664	0.00704	CcSEcCtD
Ketamine—Nausea—Miglitol—type 2 diabetes mellitus	0.000636	0.00675	CcSEcCtD
Ketamine—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000626	0.00664	CcSEcCtD
Ketamine—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000624	0.00662	CcSEcCtD
Ketamine—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.000615	0.00653	CcSEcCtD
Ketamine—Rash—Tolbutamide—type 2 diabetes mellitus	0.000607	0.00644	CcSEcCtD
Ketamine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000576	0.00611	CcSEcCtD
Ketamine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000575	0.0061	CcSEcCtD
Ketamine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000572	0.00607	CcSEcCtD
Ketamine—Shock—Glipizide—type 2 diabetes mellitus	0.000572	0.00607	CcSEcCtD
Ketamine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000565	0.00599	CcSEcCtD
Ketamine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000557	0.00591	CcSEcCtD
Ketamine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000557	0.00591	CcSEcCtD
Ketamine—Anorexia—Glipizide—type 2 diabetes mellitus	0.000554	0.00588	CcSEcCtD
Ketamine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000552	0.00586	CcSEcCtD
Ketamine—Rash—Tolazamide—type 2 diabetes mellitus	0.000552	0.00586	CcSEcCtD
Ketamine—Erythema—Glyburide—type 2 diabetes mellitus	0.000548	0.00581	CcSEcCtD
Ketamine—Rash—Linagliptin—type 2 diabetes mellitus	0.000546	0.0058	CcSEcCtD
Ketamine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000546	0.00579	CcSEcCtD
Ketamine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000542	0.00575	CcSEcCtD
Ketamine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00054	0.00574	CcSEcCtD
Ketamine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000535	0.00568	CcSEcCtD
Ketamine—Shock—Glimepiride—type 2 diabetes mellitus	0.000533	0.00566	CcSEcCtD
Ketamine—Rash—Acarbose—type 2 diabetes mellitus	0.000531	0.00563	CcSEcCtD
Ketamine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00053	0.00562	CcSEcCtD
Ketamine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00052	0.00552	CcSEcCtD
Ketamine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00052	0.00552	CcSEcCtD
Ketamine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000519	0.00551	CcSEcCtD
Ketamine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000517	0.00548	CcSEcCtD
Ketamine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000516	0.00548	CcSEcCtD
Ketamine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000516	0.00547	CcSEcCtD
Ketamine—Rash—Nateglinide—type 2 diabetes mellitus	0.000512	0.00543	CcSEcCtD
Ketamine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000511	0.00542	CcSEcCtD
Ketamine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000507	0.00538	CcSEcCtD
Ketamine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000505	0.00536	CcSEcCtD
Ketamine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000505	0.00536	CcSEcCtD
Ketamine—Nausea—Acarbose—type 2 diabetes mellitus	0.0005	0.0053	CcSEcCtD
Ketamine—DRD2—retina—type 2 diabetes mellitus	0.000497	0.0132	CbGeAlD
Ketamine—Pain—Glipizide—type 2 diabetes mellitus	0.000497	0.00527	CcSEcCtD
Ketamine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000492	0.00522	CcSEcCtD
Ketamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000482	0.00511	CcSEcCtD
Ketamine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000481	0.00511	CcSEcCtD
Ketamine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000481	0.00511	CcSEcCtD
Ketamine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000475	0.00504	CcSEcCtD
Ketamine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000471	0.005	CcSEcCtD
Ketamine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00047	0.00499	CcSEcCtD
Ketamine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000466	0.00495	CcSEcCtD
Ketamine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000462	0.0049	CcSEcCtD
Ketamine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000457	0.00485	CcSEcCtD
Ketamine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000454	0.00482	CcSEcCtD
Ketamine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000447	0.00474	CcSEcCtD
Ketamine—Rash—Repaglinide—type 2 diabetes mellitus	0.000443	0.0047	CcSEcCtD
Ketamine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000442	0.00469	CcSEcCtD
Ketamine—Shock—Glyburide—type 2 diabetes mellitus	0.00044	0.00467	CcSEcCtD
Ketamine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000426	0.00452	CcSEcCtD
Ketamine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000426	0.00452	CcSEcCtD
Ketamine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000426	0.00452	CcSEcCtD
Ketamine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000425	0.00451	CcSEcCtD
Ketamine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000421	0.00447	CcSEcCtD
Ketamine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000418	0.00444	CcSEcCtD
Ketamine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000418	0.00444	CcSEcCtD
Ketamine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000418	0.00443	CcSEcCtD
Ketamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000417	0.00443	CcSEcCtD
Ketamine—Erythema—Metformin—type 2 diabetes mellitus	0.000412	0.00437	CcSEcCtD
Ketamine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000399	0.00423	CcSEcCtD
Ketamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000394	0.00418	CcSEcCtD
Ketamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000389	0.00412	CcSEcCtD
Ketamine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000388	0.00412	CcSEcCtD
Ketamine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000388	0.00412	CcSEcCtD
Ketamine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000387	0.00411	CcSEcCtD
Ketamine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000379	0.0101	CbGeAlD
Ketamine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000375	0.00398	CcSEcCtD
Ketamine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000375	0.00398	CcSEcCtD
Ketamine—CYP2C8—kidney—type 2 diabetes mellitus	0.000371	0.00987	CbGeAlD
Ketamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000369	0.00392	CcSEcCtD
Ketamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000369	0.00391	CcSEcCtD
Ketamine—Rash—Glipizide—type 2 diabetes mellitus	0.000366	0.00389	CcSEcCtD
Ketamine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000366	0.00388	CcSEcCtD
Ketamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000366	0.00388	CcSEcCtD
Ketamine—Erythema—Losartan—type 2 diabetes mellitus	0.000366	0.00388	CcSEcCtD
Ketamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000365	0.00387	CcSEcCtD
Ketamine—Shock—Valsartan—type 2 diabetes mellitus	0.000363	0.00385	CcSEcCtD
Ketamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000352	0.00373	CcSEcCtD
Ketamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000345	0.00366	CcSEcCtD
Ketamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000345	0.00366	CcSEcCtD
Ketamine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000345	0.00366	CcSEcCtD
Ketamine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000345	0.00366	CcSEcCtD
Ketamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000344	0.00365	CcSEcCtD
Ketamine—Pain—Gliclazide—type 2 diabetes mellitus	0.000343	0.00364	CcSEcCtD
Ketamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000342	0.00363	CcSEcCtD
Ketamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000342	0.00362	CcSEcCtD
Ketamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000341	0.00362	CcSEcCtD
Ketamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00034	0.00361	CcSEcCtD
Ketamine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.00034	0.00905	CbGeAlD
Ketamine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000337	0.00896	CbGeAlD
Ketamine—CYP2B6—kidney—type 2 diabetes mellitus	0.000333	0.00886	CbGeAlD
Ketamine—Shock—Metformin—type 2 diabetes mellitus	0.000331	0.00351	CcSEcCtD
Ketamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000322	0.00342	CcSEcCtD
Ketamine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000322	0.00341	CcSEcCtD
Ketamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000321	0.00341	CcSEcCtD
Ketamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000321	0.0034	CcSEcCtD
Ketamine—Anorexia—Metformin—type 2 diabetes mellitus	0.00032	0.0034	CcSEcCtD
Ketamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000317	0.00336	CcSEcCtD
Ketamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000317	0.00336	CcSEcCtD
Ketamine—Hypotension—Metformin—type 2 diabetes mellitus	0.000314	0.00333	CcSEcCtD
Ketamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000313	0.00333	CcSEcCtD
Ketamine—Shock—Irbesartan—type 2 diabetes mellitus	0.000312	0.00331	CcSEcCtD
Ketamine—Pain—Orlistat—type 2 diabetes mellitus	0.000312	0.00331	CcSEcCtD
Ketamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000311	0.0033	CcSEcCtD
Ketamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00327	CcSEcCtD
Ketamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00327	CcSEcCtD
Ketamine—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000308	0.00818	CbGeAlD
Ketamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000302	0.00321	CcSEcCtD
Ketamine—PTGS1—kidney—type 2 diabetes mellitus	0.000301	0.00801	CbGeAlD
Ketamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000298	0.00317	CcSEcCtD
Ketamine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000296	0.00314	CcSEcCtD
Ketamine—Shock—Losartan—type 2 diabetes mellitus	0.000294	0.00311	CcSEcCtD
Ketamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000292	0.0031	CcSEcCtD
Ketamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000291	0.00308	CcSEcCtD
Ketamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000284	0.00302	CcSEcCtD
Ketamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000284	0.00302	CcSEcCtD
Ketamine—Rash—Glyburide—type 2 diabetes mellitus	0.000282	0.00299	CcSEcCtD
Ketamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000282	0.00299	CcSEcCtD
Ketamine—Hypotension—Losartan—type 2 diabetes mellitus	0.000279	0.00296	CcSEcCtD
Ketamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000276	0.00292	CcSEcCtD
Ketamine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000272	0.00288	CcSEcCtD
Ketamine—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000271	0.00722	CbGeAlD
Ketamine—Pain—Irbesartan—type 2 diabetes mellitus	0.000271	0.00288	CcSEcCtD
Ketamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000266	0.00282	CcSEcCtD
Ketamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000259	0.00275	CcSEcCtD
Ketamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000256	0.00271	CcSEcCtD
Ketamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000255	0.00271	CcSEcCtD
Ketamine—Pain—Losartan—type 2 diabetes mellitus	0.000255	0.00271	CcSEcCtD
Ketamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000253	0.00269	CcSEcCtD
Ketamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000253	0.00268	CcSEcCtD
Ketamine—Shock—Ramipril—type 2 diabetes mellitus	0.000252	0.00267	CcSEcCtD
Ketamine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000251	0.00669	CbGeAlD
Ketamine—CYP3A4—kidney—type 2 diabetes mellitus	0.000251	0.00669	CbGeAlD
Ketamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000244	0.00259	CcSEcCtD
Ketamine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000239	0.00254	CcSEcCtD
Ketamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000238	0.00253	CcSEcCtD
Ketamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000235	0.00249	CcSEcCtD
Ketamine—CYP2C8—liver—type 2 diabetes mellitus	0.000235	0.00624	CbGeAlD
Ketamine—Rash—Valsartan—type 2 diabetes mellitus	0.000233	0.00247	CcSEcCtD
Ketamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000232	0.00247	CcSEcCtD
Ketamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000232	0.00246	CcSEcCtD
Ketamine—Rash—Orlistat—type 2 diabetes mellitus	0.00023	0.00244	CcSEcCtD
Ketamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00023	0.00244	CcSEcCtD
Ketamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000222	0.00236	CcSEcCtD
Ketamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000219	0.00233	CcSEcCtD
Ketamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000217	0.0023	CcSEcCtD
Ketamine—ABCB1—retina—type 2 diabetes mellitus	0.000215	0.00572	CbGeAlD
Ketamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000214	0.00227	CcSEcCtD
Ketamine—Rash—Metformin—type 2 diabetes mellitus	0.000212	0.00225	CcSEcCtD
Ketamine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000212	0.00225	CcSEcCtD
Ketamine—CYP2B6—liver—type 2 diabetes mellitus	0.00021	0.0056	CbGeAlD
Ketamine—CYP2C9—liver—type 2 diabetes mellitus	0.000208	0.00554	CbGeAlD
Ketamine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000202	0.00539	CbGeAlD
Ketamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000202	0.00214	CcSEcCtD
Ketamine—Rash—Irbesartan—type 2 diabetes mellitus	0.0002	0.00212	CcSEcCtD
Ketamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.0002	0.00212	CcSEcCtD
Ketamine—Nausea—Metformin—type 2 diabetes mellitus	0.0002	0.00212	CcSEcCtD
Ketamine—Vomiting—Losartan—type 2 diabetes mellitus	0.00019	0.00201	CcSEcCtD
Ketamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000188	0.002	CcSEcCtD
Ketamine—Rash—Losartan—type 2 diabetes mellitus	0.000188	0.002	CcSEcCtD
Ketamine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000188	0.00199	CcSEcCtD
Ketamine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000182	0.00484	CbGeAlD
Ketamine—ABCB1—kidney—type 2 diabetes mellitus	0.000178	0.00473	CbGeAlD
Ketamine—Nausea—Losartan—type 2 diabetes mellitus	0.000177	0.00188	CcSEcCtD
Ketamine—ABCB1—pancreas—type 2 diabetes mellitus	0.000177	0.0047	CbGeAlD
Ketamine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000173	0.00461	CbGeAlD
Ketamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000163	0.00173	CcSEcCtD
Ketamine—Rash—Ramipril—type 2 diabetes mellitus	0.000161	0.00171	CcSEcCtD
Ketamine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000161	0.00171	CcSEcCtD
Ketamine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.00016	0.00427	CbGeAlD
Ketamine—CYP3A4—liver—type 2 diabetes mellitus	0.000159	0.00423	CbGeAlD
Ketamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000152	0.00161	CcSEcCtD
Ketamine—ABCB1—liver—type 2 diabetes mellitus	0.000112	0.00299	CbGeAlD
Ketamine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.19e-06	3.42e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.18e-06	3.41e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.16e-06	3.39e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.16e-06	3.39e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.15e-06	3.38e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.14e-06	3.37e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.14e-06	3.37e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.13e-06	3.37e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.12e-06	3.36e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.12e-06	3.36e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.12e-06	3.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.11e-06	3.35e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.1e-06	3.34e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.09e-06	3.34e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.07e-06	3.32e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	4.04e-06	3.29e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.03e-06	3.29e-05	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.03e-06	3.28e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.01e-06	3.27e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.99e-06	3.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.97e-06	3.24e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.96e-06	3.23e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.96e-06	3.23e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.96e-06	3.23e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—INS—type 2 diabetes mellitus	3.96e-06	3.23e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.96e-06	3.23e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.95e-06	3.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.95e-06	3.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.95e-06	3.22e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.95e-06	3.22e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.94e-06	3.22e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.92e-06	3.2e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.92e-06	3.2e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.91e-06	3.19e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.91e-06	3.19e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.9e-06	3.18e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.88e-06	3.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.87e-06	3.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.86e-06	3.15e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.86e-06	3.15e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.85e-06	3.14e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.84e-06	3.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.84e-06	3.13e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.84e-06	3.13e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.82e-06	3.12e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.8e-06	3.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.79e-06	3.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	3.78e-06	3.09e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.77e-06	3.07e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.77e-06	3.07e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.75e-06	3.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.74e-06	3.05e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.73e-06	3.04e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.73e-06	3.04e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.7e-06	3.02e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.7e-06	3.02e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.66e-06	2.98e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.65e-06	2.97e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.64e-06	2.97e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	3.63e-06	2.96e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.61e-06	2.94e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.61e-06	2.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.6e-06	2.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.6e-06	2.93e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.57e-06	2.91e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.55e-06	2.89e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.54e-06	2.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.54e-06	2.88e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.53e-06	2.88e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.52e-06	2.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.52e-06	2.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.52e-06	2.87e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.5e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.5e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.5e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.48e-06	2.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.48e-06	2.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.48e-06	2.84e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.48e-06	2.84e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.48e-06	2.83e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.48e-06	2.83e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	3.47e-06	2.83e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.47e-06	2.83e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.42e-06	2.79e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.42e-06	2.79e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.4e-06	2.77e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.39e-06	2.77e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.39e-06	2.76e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.36e-06	2.74e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.35e-06	2.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.32e-06	2.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.31e-06	2.7e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.29e-06	2.68e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.28e-06	2.67e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.27e-06	2.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.26e-06	2.66e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.22e-06	2.63e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.22e-06	2.63e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.22e-06	2.62e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.21e-06	2.61e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.19e-06	2.6e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.19e-06	2.6e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.18e-06	2.59e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	3.18e-06	2.59e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-06	2.58e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.16e-06	2.58e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.15e-06	2.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.14e-06	2.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.14e-06	2.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.14e-06	2.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.14e-06	2.56e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.14e-06	2.56e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.12e-06	2.55e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.11e-06	2.54e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.11e-06	2.53e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-06	2.51e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.07e-06	2.5e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.06e-06	2.49e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.05e-06	2.49e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.05e-06	2.48e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.05e-06	2.48e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.04e-06	2.48e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.04e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.03e-06	2.47e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.02e-06	2.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	3.01e-06	2.45e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3e-06	2.45e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.99e-06	2.44e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.98e-06	2.43e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.97e-06	2.42e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.96e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.96e-06	2.41e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.96e-06	2.41e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.96e-06	2.41e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.96e-06	2.41e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.94e-06	2.39e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-06	2.38e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.91e-06	2.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.91e-06	2.37e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.91e-06	2.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.9e-06	2.36e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.85e-06	2.32e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.84e-06	2.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.82e-06	2.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.82e-06	2.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.82e-06	2.3e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-06	2.28e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.79e-06	2.28e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.77e-06	2.26e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.77e-06	2.25e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.76e-06	2.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.76e-06	2.25e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.76e-06	2.25e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-06	2.24e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.74e-06	2.23e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.73e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.72e-06	2.22e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.71e-06	2.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.68e-06	2.19e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.67e-06	2.18e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.66e-06	2.17e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-06	2.16e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-06	2.16e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.64e-06	2.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.64e-06	2.15e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.62e-06	2.13e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.61e-06	2.13e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.58e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.58e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.57e-06	2.09e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.56e-06	2.09e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.55e-06	2.08e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.55e-06	2.08e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.51e-06	2.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.49e-06	2.03e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.48e-06	2.03e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-06	1.99e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.44e-06	1.99e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.44e-06	1.99e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.44e-06	1.99e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-06	1.98e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.41e-06	1.96e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.34e-06	1.91e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.34e-06	1.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.3e-06	1.88e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-06	1.85e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.26e-06	1.84e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.26e-06	1.84e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.24e-06	1.83e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.24e-06	1.83e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.24e-06	1.83e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	1.82e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.23e-06	1.82e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.16e-06	1.76e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-06	1.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.12e-06	1.73e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.11e-06	1.72e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.11e-06	1.72e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.1e-06	1.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.09e-06	1.71e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.08e-06	1.7e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.07e-06	1.69e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.05e-06	1.67e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.05e-06	1.67e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.05e-06	1.67e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.04e-06	1.67e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.01e-06	1.64e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-06	1.59e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-06	1.59e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.95e-06	1.59e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.95e-06	1.59e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.92e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.91e-06	1.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.9e-06	1.55e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.89e-06	1.54e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.88e-06	1.53e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-06	1.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.83e-06	1.49e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.83e-06	1.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.82e-06	1.48e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.8e-06	1.47e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	1.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.75e-06	1.42e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.74e-06	1.41e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.73e-06	1.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.71e-06	1.4e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.69e-06	1.38e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-06	1.36e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.64e-06	1.34e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-06	1.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.61e-06	1.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.6e-06	1.31e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-06	1.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-06	1.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	1.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.37e-06	1.12e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.32e-06	1.07e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	1.03e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	9.93e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.21e-06	9.89e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	9.81e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	9.81e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	8.98e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	8.41e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.98e-07	7.32e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.39e-07	6.84e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.53e-07	4.51e-06	CbGpPWpGaD
